statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update PR Newswire...

Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS PR Newswire NASHVILLE, Tenn., April 30, 2024...

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS

NEW REPORT SUPPORTS USE OF CALDOLOR AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS NEW REPORT SUPPORTS USE OF CALDOLOR AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS PR Newswire NASHVILLE, Tenn...

NEW REPORT SUPPORTS USE OF CALDOLOR AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS

StockNews.com assumed coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX - Free Report) in a research note released on Sunday. The firm issued a hold rating on the specialty pharmaceutical...

Cumberland Pharmaceuticals (NASDAQ:CPIX) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX  Free Report) in a report released on Friday. The brokerage issued a hold rating on the specialty...

Cumberland Pharmaceuticals (NASDAQ:CPIX) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX  Free Report) in a research report sent to investors on Thursday morning. The brokerage issued a hold rating...

Cumberland Pharmaceuticals (NASDAQ:CPIX) Now Covered by Analysts at StockNews.com

Cumberland Pharmaceuticals Reports Annual 2023 Financial Results Cumberland Pharmaceuticals Reports Annual 2023 Financial Results PR Newswire NASHVILLE, Tenn., March 5, 2024 2023 highlights include...

Cumberland Pharmaceuticals Reports Annual 2023 Financial Results

Investment analysts at StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX  Get Free Report) in a research report issued to clients and investors on...

StockNews.com Initiates Coverage on Cumberland Pharmaceuticals (NASDAQ:CPIX)

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTS CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTS PR Newswire NASHVILLE, Tenn., Feb. 27, 2024 NASHVILLE, Tenn...

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTS

StockNews.com began coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX  Free Report) in a research note published on Saturday. The firm issued a hold rating on the specialty...

StockNews.com Begins Coverage on Cumberland Pharmaceuticals (NASDAQ:CPIX)

Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which focuses on the acquisition, development, and commercialization of branded prescription pharmaceutical products. Its products include Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Vibativ, Sancuso, Boxaban, Vasculan. Dyscorban, and RediTrex. The company was founded by A. J. Kazimi on January 7, 1999 and is headquartered in Nashville, TN.

Watchers	1,851
52-Wk Low	$1.42
52-Wk High	$2.36

Volume	43.00
52-Wk High	$2.36
52-Wk Low	$1.42

Period	Estimated	Reported	Surprise	Result
Q3'22	--	-$0.03	--	N/A
Q2'22	--	-$0.09	--	N/A
Q1'22	--	-$0.09	--	N/A

CPIX Cumberland Pharmaceuticals Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals